Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era

• Published in: Clinical infectious diseases Vol. 73; no. 5; pp. e1222 - e1227
• Main Authors: Guaraldi, Giovanni, Milic, Jovana, Martinez, Esteban, Kamarulzaman, Adeeba, Mussini, Cristina, Waters, Laura, Pozniak, Anton, Mallon, Patrick, Rockstroh, Jürgen K, Lazarus, Jeffrey V
• Format: Journal Article
• Language: English
• Published: US Oxford University Press 07.09.2021
• Subjects: COVID-19; AIDS care; HIV; quality of life
• ISSN: 1058-4838; 1537-6591
• DOI: 10.1093/cid/ciaa1864

Abstract The coronavirus disease 2019 (COVID-19) pandemic is an unprecedented global challenge that substantially risks reversing the progress in ending human immunodeficiency virus (HIV). At the same time, it may offer the opportunity for a new era of HIV management. This viewpoint presents the impact of COVID-19 on HIV care, including the Joint United Nations Programme on HIV/AIDS (UNAIDS) “three 90s” targets. It outlines how to enhance a patient-centered care approach, now known as the “fourth 90,” by integrating face-to-face patient–physician and telemedicine encounters. It suggests a framework for prevention and treatment of multimorbidity and frailty, to achieve a good health-related quality of life, and to preserve intrinsic capacity in all people living with HIV. Human Immunodeficiency Virus (HIV) care during the COVID-19 pandemic requires changes in healthcare delivery. The use of telemedicine, for example, can help compensate for the reduction in face-to-face patient–physician encounters and accelerate a new HIV care model.